Soha Azadi

Soha Azadi

Auto-generated profile, based on publicly available information

Soha Azadi

Department of Clinical Pharmacy School of Pharmacy Shiraz University of Medical Sciences Shiraz Iran

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2023 in Surgical Infections
Verified
Journal Article
Closed access
MSMojtaba shafiekhani
Mojtaba shafiekhani
SFSeyed Amirreza Fatemi
Seyed Amirreza Fatemi
PHPouria Hosseini
Pouria Hosseini
FMFatemeh Marhemati
Fatemeh Marhemati
SMSoniya Mohammadi
Soniya Mohammadi
SASoha Azadi
Soha Azadi
Background: Currently, the escalation of microbial resistance poses a significant global challenge. Children are more susceptible to develop infections and therefore are prescribed antibiotics more frequently. The overuse and misuse of antibiotics in pediatric patients can play a considerable role in developing microbial resistance. Accordingly, many policies, including research into new antibiotic agents have been recommended to combat microbial resistance. Recent developments in novel antibiotics have shown promising results against multi-drug resistant (MDR) and extensive drug resistance (XDR) pathogens. However, as pediatric patients are typically excluded from the clinical trials of new medications, labeling and information about approved antibiotics should be improved. This study aimed to evaluate antibiotics having been introduced to the market in the last decade focusing on pediatric population. Methods: This study reviewed the published literatures on novel FDA-approved antibiotics released between 2010 and 2022. Results: Finally, seven newly approved antibiotics including ceftaroline fosamil, ceftazidime-avibactam, ceftolozane-tazobactam, ceftobiprole, imipenem-cilastatin-relebactam, meropenem-vaborbactam, and tedizolid were considered in the present review-article. All relevant data extracted from literatures, were discussed in different subtitles of “Pharmacology”, “Mechanism of action”, “Indication”, “Dosage regimen and pharmacokinetic and pharmacodynamic properties”, “Dosage adjustment in renal/liver failure”, “Resistance pattern”, and “Adverse drug events”. Conclusion: This study reviewed available data on seven new antibiotic agents and their pharmacodynamic and pharmacokinetic properties, with a particular focus on their use in pediatric patients. The information presented in this review will be useful for healthcare professionals in selecting appropriate antibiotics for pediatric patients and for researchers in achieving the ideal therapeutic regimens.

1 August 2025 in Musculoskeletal Care
Verified
Journal Article
Closed access
LMLaleh Mahmoudi
Laleh Mahmoudi
SSSeyed Mahdi Sadati
Seyed Mahdi Sadati
HFHamid Reza Farpour
Hamid Reza Farpour
MAMohammad Abbasinazari
Mohammad Abbasinazari
NMNegar Mortazavi
Negar Mortazavi
SASoha Azadi
Soha Azadi